Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails

Eli Lilly, Amgen join forces to scale production of COVID-19 antibody cocktails

Source: 
Fierce Pharma
snippet: 

Eli LIlly and Amgen have teamed up to scale manufacturing of future antibody cocktails, including Lilly's LY-CoV-55, in testing to treat COVID-19, the partners said Thursday.